E-LIB Suche - Ergebnisse für: Bognar, K.

1

EE321 Cost Impact of Next Generation Sequencing Testing in ..:

Cuyún Carter, G. ; Thakkar, S. ; Bognar, K....
Value in Health. 26 (2023) 6 - p. S118 , 2023

Link: https://doi.org/10.1016/..

2

EE385 Value of Next Generation Sequencing (NGS) Using the O..:

Ortendahl, J.D. ; Cuyún Carter, G. ; Thakkar, S...
Value in Health. 26 (2023) 6 - p. S130 , 2023

Link: https://doi.org/10.1016/..

3

CO179 Potential Health and Economic Outcomes of a Blood-Bas..:

Bach, P.B. ; Ortendahl, J.D. ; Bognar, K...
Value in Health. 26 (2023) 6 - p. S48 , 2023

Link: https://doi.org/10.1016/..

4

EE293 Diagnostic Hospitalization and Associated Costs in Pa..:

Quock, TP ; Chang, E ; Bognar, K...
Value in Health. 25 (2022) 7 - p. S391 , 2022

Link: https://doi.org/10.1016/..

5

Measurements of Tropospheric Bromine Monoxide Over Four Hal..:

Bognar, K. ; Zhao, X. ; Strong, K....
Journal of Geophysical Research: Atmospheres. 125 (2020) 18 - p. , 2020

Link: https://doi.org/10.1029/..

6

PCN86 HOSPITAL SHARE OF PROFITS FROM PHYSICIAN-ADMINISTERED..:

Ortendahl, J. ; Bognar, K.
Value in Health. 23 (2020) - p. S38-S39 , 2020

Link: https://doi.org/10.1016/..

7

Updated validation of ACE and OSIRIS ozone and NO2 measurem..:

Bognar, K. ; Zhao, X. ; Strong, K....
Journal of Quantitative Spectroscopy and Radiative Transfer. 238 (2019) - p. 106571 , 2019

Link: https://doi.org/10.1016/..

8

PCN143 HOW MUCH DO INDIVIDUALS VALUE ACCESS TO INNOVATIVE L..:

Bognar, K. ; Shafrin, J. ; May, S.G....
Value in Health. 22 (2019) - p. S83 , 2019

Link: https://doi.org/10.1016/..

9

PCN154 INCORPORATING THE VALUE HEALTHY INDIVIDUALS PLACE ON..:

Shafrin, J. ; May, S. ; Zhao, L.M....
Value in Health. 22 (2019) - p. S465 , 2019

Link: https://doi.org/10.1016/..

10

Comparative efficacy and safety of nivolumab (nivo) vs rele..:

Shrestha, A. ; Penrod, J.R. ; Reck, M....
European Journal of Cancer. 72 (2017) - p. S136 , 2017

Link: https://doi.org/10.1016/..

11

Comparative efficacy and safety of nivolumab (nivo) vs rele..:

Eberhardt, W.E.E. ; Vanderpuye-Orgle, J. ; Reck, M....
European Journal of Cancer. 72 (2017) - p. S136 , 2017

Link: https://doi.org/10.1016/..

12

ARE FINANCIAL INCENTIVES IN PAY-FOR-PERFORMANCE PROGRAMS SU..:

Bognar, K. ; Shafrin, J. ; Sheehan, J..
Value in Health. 19 (2016) 3 - p. A210-A211 , 2016

Link: https://doi.org/10.1016/..

13

Financial implications of a hospital early mobility program:

Bognar, K ; Chou, JW ; McCoy, D...
Intensive Care Medicine Experimental. 3 (2015) S1 - p. , 2015

Link: https://doi.org/10.1186/..

14

Health Care Costs And Clinical Outcomes Associated With Rat..:

Bognar, K. ; Bell, K. ; Lakdawalla, D.N....
Value in Health. 16 (2013) 3 - p. A173-A174 , 2013

Link: https://doi.org/10.1016/..

15

Seawater reverse osmosis (SWRO) as deferrable load in micro..:

Bognar, K. ; Pohl, R. ; Behrendt, F.
Desalination and Water Treatment. 51 (2013) 4-6 - p. 1190-1199 , 2013

Link: https://doi.org/10.1080/..